FDA Approves TEVIMBRA® for First-Line Treatment of PD-L1-Positive Gastric and Gastroesophageal Junction Cancers

CSIR's 2024 Healthcare Breakthroughs: Advancing Cancer Detection, Genetic Disorders, and Neurodegenerative Disease Research

Dr. Sandip Shah Appointed Chairman of NABL: A Visionary Leader in Indian Healthcare

Global and Indian Genetic Testing Market Trends in 2025

Mankind Pharma and Innovent Biologics Partner to Launch Groundbreaking PD-1 Immunotherapy in India

Duchenne Muscular Dystrophy: Diagnosis, Treatment, and Emerging Therapies

Ikena Oncology and Inmagene Biopharmaceuticals Announce Merger to Form ImageneBio

Fujirebio and Eisai Partner to Advance Diagnostics for Neurodegenerative Diseases

European Commission Approves Opdivo® Plus Yervoy® for First-Line Treatment of MSI-H or dMMR mCRC

Deerfield Management to Acquire Singular Genomics for $20 Per Share in All-Cash Deal

EU Approval of Tagrisso Sets New Standard for EGFR-Mutated NSCLC Treatment

Aurobindo Pharma’s Subsidiary CuraTeQ Secures UK Approval for Bevacizumab Biosimilar

SCG Cell Therapy Partners with A*STAR BTI and NATi to Advance RNA-Based Therapeutics

Korea's National Bio Big Data Project: Advancing Precision Medicine with Macrogen and Illumina

GST Exemption Announced for Cancer Treatment Gene Therapy

Home
/
update
/
details

Amrita Hospital in India Launches CAR T Cell Therapy Centre

NextEdge Admin

10 Jul 2024

1 min 32 sec

Amrita Hospital has inaugurated its Centre of Excellence for CAR T Cell Therapy, marking a significant advancement in cancer treatment within India. The hospital stated that CAR-T cell therapy utilizes the body's immune system to precisely target cancer cells, offering new hope to patients with previously untreatable conditions. This groundbreaking approach is noted for its potential to achieve long-term remission in certain blood cancers.

The inauguration ceremony was officiated by Shri George Kurian, Minister of State for Fisheries, Animal Husbandry and Dairying, and Minority Affairs, who emphasized India's progress in healthcare. He highlighted that advanced treatments like CAR T Cell Therapy are now accessible domestically, reducing the need for patients to seek costly treatments abroad. Dr. Prathapan Nair P., Chairman of Amrita Health Sciences, and other key figures from Amrita Hospital were also present at the event, underscoring the institution's commitment to providing world-class healthcare at affordable costs, in alignment with its founding principles.